| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | Director
3 companies
Jeffs Roger is a Chief Executive Officer at LQDA, with reported holdings spanning 3 companies. Recent filings cover 7 purchases and 48 sales. Those positions are worth an estimated $46.7M at current prices.
Our model assigns Jeffs Roger a middling insider score of 64/100, based on 25 past trades. Over a 12-month horizon, 50.0% of those trades were profitable, with an average 12-month return of -18.2%.
Jeffs Roger's largest disclosed position is in LQDA as Chief Executive Officer, worth about $32.1M. The recent filings there lean toward selling, a net 536,560 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 16, 2026 | LQDA Liquidia Corporation | Chief Executive Officer | Sell | 53,300 | $40.21 | $2,143,322.50 | -3.6% | +87.8% | - | |
| Apr 13, 2026 | LQDA Liquidia Corporation | Chief Executive Officer | Sale+OE | 54,177 | $39.06 | $2,116,264.24 | -2.0% | +83.3% | - | |
| Apr 9, 2026 | LQDA Liquidia Corporation | Chief Executive Officer | Sell | 25,000 | $40.12 | $1,002,887.50 | -1.6% | +97.1% | - | |
| Jan 12, 2026 | LQDA Liquidia Corp | Chief Executive Officer | Sale+OE | 66,610 | $37.43 | $2,493,212.30 | -6.0% | +6.1% | - | |
| Oct 13, 2025 | LQDA Liquidia Corp | Chief Executive Officer | Sale+OE | 20,261 | $23.41 | $474,310.01 | -1.9% | +54.0% | +12.8% | |
| Sep 2, 2025 | AXSM Axsome Therapeutics, Inc. | Director | Sell | 13,464 | $123.68 | $1,665,227.52 | -19.0% | +20.7% | +70.0% | |
| Aug 29, 2025 | AXSM Axsome Therapeutics, Inc. | Director | Sell | 60,000 | $121.72 | $7,303,400.00 | -45.8% | +24.9% | +64.1% | |
| Aug 26, 2025 | AXSM Axsome Therapeutics, Inc. | Director | Sell | 36,694 | $120.05 | $4,405,215.52 | -21.9% | +24.8% | +71.0% | |
| Jul 14, 2025 | LQDA Liquidia Corp | Chief Executive Officer | Sale+OE | 20,252 | $14.28 | $289,198.56 | -1.9% | +64.2% | +428.2% | |
| Jul 14, 2025 | LQDA Liquidia Corp | Chief Executive Officer | Sale+OE | 20,252 | $14.28 | $289,198.56 | -1.9% | +64.2% | +428.2% |